A proof-of-concept created by Brock Heinz of Spaulding Clinical could have interesting implications for the future of clinical trials.
That’s the topic I explore in a recent two-part guest post on Medidata’s Geeks Talk Clinical blog.
In the two-part series I discuss:
- Why most patients have little interest in clinical trials
- Why EHRs are not enough to overcome patient recruitment challenges
- The “quantified self” movement and its importance
- Heinz’s proof-of-concept and what it might mean for a new virtual clinical trial model
- The 3 overarching benefits of this new clinical trial model
- Overcoming barriers to creating a new and improved clinical trial model
Read my guest blog post here:
What a New Proof-of Concept Might Mean for Clinical Trials of the Future (Part 1)
What a New Proof-of Concept Might Mean for Clinical Trials of the Future (Part 2)
I’d love to hear your thoughts about the future of clinical trials. Get in touch via Twitter, Linkedin, or email.
Leave a Reply